Gritstone bio, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm

Core Viewpoint - Gritstone bio, Inc. is facing a class action lawsuit due to allegations of making false and misleading statements regarding its Phase 2b CORAL Study and its commercialization capabilities, which led to investor losses when the truth was revealed [1]. Group 1: Company Misconduct - The Company allegedly failed to launch its Phase 2b CORAL Study within the promised timeframe, impacting its ability to secure external funding [1]. - Gritstone overstated its ability to commercialize its products, leading to materially misleading public statements throughout the class period [1]. - Investors suffered damages when the market became aware of the true situation regarding Gritstone [1]. Group 2: Legal Actions - A class action has been filed on behalf of Gritstone investors who lost money, encouraging affected investors to contact the Portnoy Law Firm for assistance [2]. - The Portnoy Law Firm specializes in representing investors in claims related to corporate wrongdoing and has a history of recovering significant amounts for aggrieved investors [3]. - Investors who engaged with Gritstone shares between March 9, 2023, and February 29, 2024, are invited to discuss their legal rights and options for recovering losses [5].